Bayley Matthew D 4
4 · Aevi Genomic Medicine, Inc. · Filed Dec 4, 2017
Insider Transaction Report
Form 4
Bayley Matthew D
Director
Transactions
- Award
Stock Option (Right to Purchase)
2017-12-04+40,000→ 40,000 totalExercise: $1.25Exp: 2027-12-04→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]The option award vests and becomes exercisable in three equal installments (rounded up to the nearest whole share of common stock) on December 4, 2018, December 4, 2019 and December 4, 2020, subject to the reporting person's continued service with the issuer.